title: Biliary liver cirrhosis secondary to cystic fibrosis: a rare indication for liver transplantation.
abstract: As more effective therapies prolong the lives of patients with cystic fibrosis, there are now more patients in this population diagnosed with liver diseases. Secondary biliary cirrhosis is not a rare complication of mucoviscidosis. It is diagnosed in 20% of patients with mucoviscidosis; in 2% it is accompanied by portal hypertension. On average patients with portal hypertension and its complications are 12 years old. Liver transplantation is an accepted method of treatment for children with cystic fibrosis and portal hypertension. It eliminates the cause of the portal hypertension, decreases life-threatening medical conditions, and improves their nutritional status and quality of life. Despite immunosuppressive treatment they do not seem to beat increased risk of upper respiratory tract infections. On the contrary improved respiratory function and status are generally observed. We present our first case of orthotopic liver transplantation performed in a 29-year-old man with cystic fibrosis. The donor was a 42-year-old woman who died of a ruptured cerebral aneurysm. The surgery was performed in September 2004. The patient received immunosuppression based on steroids, basiliximab, tacrolimus, and mycophenolic acid due to renal insufficiency. Antibiotic (meropenem) and antiviral prophylaxis (gancyclovir) were used. A 6-month period of observation confirmed the clinical data from the pediatric population-a good prognosis with improved nutritional status, respiratory function, and quality of life.
authors.affiliation: Transplantation Institute, Department of Immunology, Transplantology and Internal Diseases, Warsaw Medical University, Nowogrodzka 59, 02-006 Warsaw, Poland. joannaresmer@poczta.onet.pl
authors.forename: J
authors.initials: J
authors.lastname: Sańko-Resmer
authors.forename: L
authors.initials: L
authors.lastname: Paczek
authors.forename: J
authors.initials: J
authors.lastname: Wyzgał
authors.forename: J
authors.initials: J
authors.lastname: Ziółkowski
authors.forename: M
authors.initials: M
authors.lastname: Ciszek
authors.forename: A
authors.initials: A
authors.lastname: Alsharabi
authors.forename: I
authors.initials: I
authors.lastname: Grzelak
authors.forename: R
authors.initials: R
authors.lastname: Paluszkiewicz
authors.forename: W
authors.initials: W
authors.lastname: Patkowski
authors.forename: M
authors.initials: M
authors.lastname: Krawczyk
mesh_terms: D000328:Adult; D003550:Cystic Fibrosis / Q000097:blood / Q000175:diagnosis*; D006801:Humans; D008105:Liver Cirrhosis, Biliary / Q000097:blood / Q000209:etiology* / Q000601:surgery*; D008111:Liver Function Tests; D016031:Liver Transplantation; D008297:Male; D016896:Treatment Outcome